Wenfeng Yu

1.4k total citations · 1 hit paper
31 papers, 965 citations indexed

About

Wenfeng Yu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Wenfeng Yu has authored 31 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Wenfeng Yu's work include Lung Cancer Diagnosis and Treatment (7 papers), Immune cells in cancer (6 papers) and RNA modifications and cancer (5 papers). Wenfeng Yu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Immune cells in cancer (6 papers) and RNA modifications and cancer (5 papers). Wenfeng Yu collaborates with scholars based in China, United States and Czechia. Wenfeng Yu's co-authors include E. Richard Stanley, Yee-Guide Yeung, Violeta Chiţu, Sayan Nandi, Xiaoqin An, Daolin Tang, Jinbao Liu, Yang Li, Xin Chen and Lewis T. Williams and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wenfeng Yu

31 papers receiving 955 citations

Hit Papers

Oxidative cell death in cancer: mechanisms and therapeuti... 2024 2026 2025 2024 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oxidative cell death in cancer: mechanisms and therapeutic opportunities
    2024 204 citations Xiaoqin An, Wenfeng Yu et al. Cell Death and Disease profile →

Peers

Wenfeng Yu
Rongze Lu United States
Kader Yagiz United States
Georg Ostermann Germany
Т. А. Смирнова Russia
Sharareh Gholamin United States
Jürgen Brück Germany
Sandy Azzi France
Shilpak Chatterjee United States
Rongze Lu United States
Wenfeng Yu
Citations per year, relative to Wenfeng Yu Wenfeng Yu (= 1×) peers Rongze Lu

Countries citing papers authored by Wenfeng Yu

Since Specialization
Citations

This map shows the geographic impact of Wenfeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Yu more than expected).

Fields of papers citing papers by Wenfeng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Yu. The network helps show where Wenfeng Yu may publish in the future.

Co-authorship network of co-authors of Wenfeng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Yu. A scholar is included among the top collaborators of Wenfeng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Yu. Wenfeng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
An, Xiaoqin, Wenfeng Yu, Jinbao Liu, et al.. (2024). Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death and Disease. 15(8). 204 indexed citations breakdown →
2.
He, Jun, et al.. (2024). The application of artificial intelligence in diagnosis of Alzheimer’s disease: a bibliometric analysis. Frontiers in Neurology. 15. 1510729–1510729. 6 indexed citations
3.
Li, Cheng‐Peng, et al.. (2024). The effect of tau K677 lactylation on ferritinophagy and ferroptosis in Alzheimer's disease. Free Radical Biology and Medicine. 224. 685–706. 20 indexed citations
4.
Yu, Wenfeng, Honghai Ma, Guocan Yu, et al.. (2023). Non‑diagnostic electromagnetic navigation bronchoscopy biopsy: Predictive factors and final diagnoses. Oncology Letters. 25(4). 166–166. 1 indexed citations
5.
Yu, Wenfeng, et al.. (2023). TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma. Scientific Reports. 13(1). 5006–5006. 5 indexed citations
6.
Yu, Wenfeng, et al.. (2022). Predictive value of matrix metalloprotease 9 on surgical outcomes after pericardiectomy. Journal of Cardiothoracic Surgery. 17(1). 50–50. 2 indexed citations
7.
Yu, Guocan, Yanqin Shen, Fangming Zhong, et al.. (2022). Diagnostic accuracy of nanopore sequencing using respiratory specimens in the diagnosis of pulmonary tuberculosis. International Journal of Infectious Diseases. 122. 237–243. 25 indexed citations
8.
Zhu, Pengfei, Xudong Xu, Bo Ye, et al.. (2022). A nomogram to predict residual cavity formation after thoracoscopic decortication in chronic tuberculous empyema. Interactive Cardiovascular and Thoracic Surgery. 34(5). 760–767. 1 indexed citations
9.
Yu, Guocan, et al.. (2021). Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis. PLoS ONE. 16(6). e0252829–e0252829. 2 indexed citations
10.
Yu, Guocan, et al.. (2021). The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma. PeerJ. 9. e12277–e12277. 6 indexed citations
11.
Zheng, Hong, et al.. (2021). Effects of Intraoperative Fluid Management on Postoperative Outcomes After Pericardiectomy. Frontiers in Surgery. 8. 673466–673466. 3 indexed citations
12.
Liang, Pan, Xingyu Liu, Weidong Wang, et al.. (2021). The Influence of Different Treatment Strategies on the Long-Term Prognosis of T1 Stage Esophageal Cancer Patients. Frontiers in Oncology. 11. 700088–700088. 4 indexed citations
13.
Huang, Sha, Tianyu He, Sijia Yang, et al.. (2020). Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2. Translational Lung Cancer Research. 9(6). 2337–2355. 44 indexed citations
14.
15.
Yu, Wenfeng, et al.. (2020). A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma. BMC Cancer. 20(1). 429–429. 9 indexed citations
16.
Yu, Wenfeng, et al.. (2020). [Clinical Evaluation of Absorbable Regenerated Oxidized Cellulose in Lung Cancer Surgery].. SHILAP Revista de lepidopterología. 23(6). 492–495. 2 indexed citations
17.
Zhao, Yan, Cheng Chang, Qichen Cao, et al.. (2015). Mining the human plasma proteome with three-dimensional strategies by high-resolution Quadrupole Orbitrap Mass Spectrometry. Analytica Chimica Acta. 904. 65–75. 18 indexed citations
18.
Yu, Wenfeng, Jian Chen, Ying Xiong, et al.. (2012). Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807. Journal of Biological Chemistry. 287(17). 13694–13704. 69 indexed citations
19.
Wei, Suwen, Sayan Nandi, Violeta Chiţu, et al.. (2010). Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. Journal of Leukocyte Biology. 88(3). 495–505. 289 indexed citations
20.
Xiong, Ying, et al.. (2010). A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation. Journal of Biological Chemistry. 286(2). 952–960. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongze Lu Breakdown of academic impact, for papers by Kader Yagiz Breakdown of academic impact, for papers by Georg Ostermann Breakdown of academic impact, for papers by Т. А. Смирнова Breakdown of academic impact, for papers by Sharareh Gholamin Breakdown of academic impact, for papers by Jürgen Brück Breakdown of academic impact, for papers by Sandy Azzi Breakdown of academic impact, for papers by Shilpak Chatterjee
Rankless by CCL
2026